Afternoon Symposium - Middle East Fertility Society Symposium - An OHSS-Free IVF Clinic: Should This Be a Goal and Is It Possible?
Time:4:15 pm - 6:15 pm
Location:Room 21 - San Diego Convention Center
Suheil J. Muasher, M.D. (Chair), The Muasher Center for Fertility and IVF
James M. Goldfarb, M.D., Cleveland Clinic
Paul Devroey, M.D., Ph.D., Centre for Reproductive Medicine, Brussels
Botros B. Rizk, M.D., University of South Alabama
An OHSS-Free IVF Clinic: Should This Be a Goal and Is It Possible?
Needs Assessment and Description
Ovarian hyperstimulation syndrome (OHSS) is one of the
most morbid complications of in vitro fertilization (IVF)
treatment with an estimated mortality rate of 3 per 100,000
stimulated cycles. The incidence that is usually quoted to
patients is 2% to 3%, but it is much higher in patients who are
young, have a lean body mass and are hyper-responders
(more than 15 oocytes recruited) to stimulation. This live
course will educate practitioners on the recognition of
patients at increased risk so that all measures are taken to
prevent OHSS. IVF success should be defined not only by
successful live births but also by eliminating OHSS in patients
At the conclusion of this session, participants should be able
- Identify patient profiles that are at risk of developing
- Assess measures that will help eliminate the syndrome.
- Measure success from IVF by live births as well as by
absence of OHSS.
After participating in this session, in my practice I will:
- Use the same dosage of gonadotropins for all my IVF
- Strive to recruit the maximum number of oocytes for all
- Use milder forms of stimulation in patients at risk for OHSS.
- Not worry about OHSS as it is very rare and can be
treated successfully in most patients.
- Not applicable to my area of practice.